Mammographic Density
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 1 programs with unclassified modality
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Havah TherapeuticsAustralia - North Adelaide
2 programs2
enobosarmPhase 11 trial
testosterone anastrozolePhase 1Small Molecule1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Havah Therapeuticstestosterone anastrozole
Havah Therapeuticsenobosarm
Clinical Trials (2)
Total enrollment: 20 patients across 2 trials
A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole
Start: Aug 2017Est. completion: Apr 201811 patients
Phase 1Completed
Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density
Start: Feb 2017Est. completion: Mar 20189 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.